US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 0.931
  • -0.009-0.95%
Close Feb 14 16:00 ET
  • 0.931
  • 0.0000.00%
Post 20:01 ET
61.34MMarket Cap-0.72P/E (TTM)

About IO Biotech Company

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.

Company Profile

SymbolIOBT
Company NameIO Biotech
Listing DateNov 5, 2021
Issue Price14.00
Founded2014
CEODr. Mai-Britt Zocca, PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
AddressOle Maal?es Vej 3
CityCopenhagen
ProvinceNorth Denmark
CountryDenmark
Zip Code2200
Phone45-70-70-29-80
Websitehttp://www.iobiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mai-Britt Zocca, PhD
  • Chief Executive Officer, President and Director
  • 1.65M
  • Amy Sullivan, M.B.A.
  • Chief Financial Officer
  • --
  • Dr. Qasim Ahmad, M.D.
  • Chief Medical Officer
  • 920.76K
  • Dr. Peter Hirth, PhD
  • Chairman of the Board
  • 145.75K
  • David V. Smith, M.B.A.
  • Independent Director
  • 124.17K
  • Dr. Helen Collins, M.D.
  • Independent Director
  • 52.48K
  • Dr. Christian Elling, PhD
  • Independent Director
  • 114.14K
  • Kathleen Sereda Glaub, M.B.A.
  • Independent Director
  • 133.00K
  • Heidi Hunter
  • Independent Director
  • 112.61K
  • Devin Whittemore Smith
  • General Counsel
  • 917.30K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?